CNTA
Centessa Pharmaceuticals Plc : Leerink Partners Raises Target Price to $24 From $22
时间：2024-11-20 19:16:34 市场： 综合 美股
Centessa Pharmaceuticals Plc : B. Riley Initiates Coverage With Buy Rating; Price Target $33
时间：2024-09-19 11:42:29 市场： 美股 综合
Centessa Pharmaceuticals Files Mixed Shelf; Launches $150 Million Offering of American Depositary Shares Centessa Pharmaceuticals (CNTA) on Wednesday filed a registration statement covering the potential sale of its securities from time to time.The filing covers ordinary shares, American depositary shares, debt securities, warrants, and units.Net proceeds will be primarily for general corporate purposes, the company said, adding it may also use part of the proceeds to pay interest or principal on debt and/or buy and invest in companies, products and technologies.Separately, Centessa said Wednesday it has started an underwritten public offering of $150 million of American depositary shares.The company said it plans to give the underwriters a 30-day option to buy up to an additional $22.5 million of ADSs.The planned offering is subject to market conditions, and there's no assurance as to whether or when it may be completed, or as to its size or terms, Centessa added.
时间：2024-09-12 05:07:03 市场： 美股 综合
Centessa Pharmaceuticals Plc : Guggenheim Raises Target Price to $24 From $20
时间：2024-09-11 18:27:08 市场： 综合 美股
Centessa Pharmaceuticals Plc : Leerink Partners Raises Target Price to $22 From $14
时间：2024-09-11 12:09:31 市场： 美股 综合
Top Midday Gainers BIO-key International (BKYI) said Tuesday that it received more than $500,000 in new orders for its biometric user authentication service without disclosing the name of the country whose defense ministry awarded the contract.Shares were up 94% as intraday trading volume catapulted to more than 137.2 million versus a daily average of about 11,000.Oracle (ORCL) shares jumped after multiple price target hikes from analysts, following the company's fiscal Q1 results.The database management group reported, late Monday, higher fiscal Q1 non-GAAP earnings and revenue that exceeded the average analyst estimates from Capital IQ.Shares of the technology giant climbed 11%, with intraday trading volume at over 28.6 million compared with a daily average of about 8.26 million.Centessa Pharmaceuticals (CNTA) shares rose 2% after the company said ORX750 was found to restore wakefulness in acutely sleep-deprived healthy volunteers.More than 3.31 million shares of the company traded i
时间：2024-09-11 02:09:38 市场： 美股 综合
Sector Update: Health Care Health care stocks were advancing Tuesday afternoon, with the NYSE Health Care Index edging up 0.1% and the Health Care Select Sector SPDR Fund (XLV) adding 0.4%.The iShares Biotechnology ETF (IBB) shed 0.2%.In corporate news, Centessa Pharmaceuticals (CNTA) shares popped more than 3% after the company said ORX750 was found to restore wakefulness in acutely sleep-deprived healthy volunteers.
时间：2024-09-11 01:42:24 市场： 综合 美股
Centessa Pharmaceuticals Shares Up After Drug Trial Found to Restore Wakefulness in Subjects Centessa Pharmaceuticals (CNTA) shares were up nearly 4% in recent Tuesday trading after the company said ORX750 was found to restore wakefulness in acutely sleep-deprived healthy volunteers.Interim results from an ongoing phase 1 trial of the company's experimental medicine found that the higher dose of the drug restored normative wakefulness in subjects, with participants staying awake for an average of 32 minutes.Based on the interim data, the company said it plans to advance the medicine into phase 2 studies in subjects with narcolepsy type 1, narcolepsy type 2, and idiopathic hypersomnia beginning in Q4.Price: 15.47, Change: +0.54, Percent Change: +3.62
时间：2024-09-11 01:03:45 市场： 美股 综合